Christopher Mitchell, M.D., joins Christiana Care as director of Robotic Surgery at the Helen F. Graham Cancer Center & Research Institute. He also joins Brandywine Urology Consultants in Wilmington.
Dr. Mitchell brings expertise in some of the most advanced and complex minimally invasive robotic surgical techniques in the field of urology today. With his arrival, Christiana Care is one of only a handful of centers in the United States to offer holmium laser enucleation of the prostate. This new procedure is shown to be highly effective in treating enlarged prostate or BPH (benign prostate hyperplasia), a non-cancerous condition that affects most men as they age.
He specializes in minimally invasive robotic surgery to treat benign and malignant diseases of the genitourinary tract, including partial nephrectomy for kidney tumors, prostatectomy for prostate cancer and complex ureteral reconstruction.
Dr. Mitchell graduated from Villanova University in 2004 with a bachelor’s degree in Biology. He earned his Medical Degree from the University of Maryland in 2008, where he received the Gold Medal Award, presented to one graduate with outstanding scholarly accomplishments.
Following a one-year internship in general surgery at the Mayo Clinic in Rochester, Minn., Dr. Mitchell completed residency training in urology (2009-2013) also at the Mayo Clinic. He completed a two-year fellowship in laparoscopy/ endourology at Vanderbilt Medical Center in Nashville, Tenn. (2013-2015).
Dr. Mitchell’s research focuses on developing new robotics procedures and robotic technologies. He is collaborating currently with a team of surgeons and engineers to design and develop a new transurethral robot to improve surgery for benign prostate conditions. He has presented both nationally and internationally on the topics of kidney cancer, prostate cancer, BPH and stone disease. His work is published in numerous peer-reviewed journals including the Journal of Urology, the Journal of Endourology, Urology and in BJU International.